JRO study summary

Simple summary as per UCLH JRO interventional studies protocol

IRAS Number

REC Reference No.

Sponsor Reference No.

Other research reference number(s) (if applicable)

(e.g. UCL Data Protection number)

Full (Scientific) title

INGLES-Resistance In‑situ Nudges for Guidelines, Local resistance, Estimated Susceptibility

Health condition(s) or problem(s) studied

Bug-drug mismatch via electronic point-of-care alerts about historical resistance

Study Type i.e. Cohort etc

Randomised controlled trial

Aim(s):

Reduce bug-drug mismatch when prescribing antibiotics through targeted notifications about historical resistance at the point of care

Objectives:

Primary To reduce the proportion of new antibiotic prescriptions that have a recent documented risk of antibiotic resistance on laboratory testing

Secondary - balancing measures

To reduce or preserve rates of of 'watch' or 'reserve' antibiotic prescriptions

Secondary - patient centred

To reduce the rate of antibiotic treatment failure (e.g. subsequent switch to broader spectrum)

To reduce complications associated with antibiotic prescribing (resistance, diarrhoea etc.)

Type of trial:

Single centre, parallel assignment, randomised controlled trial without masking

Trial design and methods:

PICO

Trial duration per participant:

7 days

Key Study milestones

  • Approved peer review of protocol

  • JRO submission and sponsorship

  • HRA and NHS REC approval

  • 1st patient recruited

Estimated total trial duration:

Planned trial sites:

University College Hospital London

Total number of participants planned:

Main inclusion/exclusion criteria:

Patients presenting to UCLH with a new community acquired urinary tract infection

Statistical methodology and analysis:

Briefly describe the statistical methodology to be used in the trial.

FUNDING & OTHER

-

Funding

UCLH Biomedical Research Centre

Other support

Insert details of the non-financial support given, and the names & contact details of all organisation providing the non-financial support.

STORAGE of SAMPLES / DATA (if applicable)

-

Human tissue samples

Insert name and contact details for where samples will be transferred and/or analysed if external to the organisation.

Data collected / Storage

Insert name and contact details were the data will be transferred to for storage and analysis if external to the research group and institution.

KEY STUDY CONTACTS

Full contact details including phone, email and fax numbers

-

Committees

Name(s) of committees, full contact details including, phone and email. E.g. study steering groups. For each committee/group, the protocol should state their roles and responsibilities and degree of independence from the Sponsor and Investigators.

Sub-contractors

Other relevant study personnel

(E.g. Data Custodian and Data Processors)

Last updated